[1]毛 焕,潘建立,王长友.NLRP3炎症小体基因在HPV感染子宫颈细胞中的表达差异研究[J].医学信息,2023,36(06):114-119.[doi:10.3969/j.issn.1006-1959.2023.06.025]
　MAO Huan,PAN Jian-li,WANG Chang-you.Differential Expression of NLRP3 Inflammasome Gene in HPV-infected Cervical Cells[J].Journal of Medical Information,2023,36(06):114-119.[doi:10.3969/j.issn.1006-1959.2023.06.025]
点击复制

NLRP3炎症小体基因在HPV感染子宫颈细胞中的表达差异研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年06期
页码:
114-119
栏目:
论著
出版日期:
2023-03-15

文章信息/Info

Title:
Differential Expression of NLRP3 Inflammasome Gene in HPV-infected Cervical Cells
文章编号:
1006-1959（2023）06-0114-06
作者:
毛 焕; 潘建立; 王长友
（天津市蓟州区人民医院病理科1，普外科2，天津 301900）
Author(s):
MAO Huan; PAN Jian-li; WANG Chang-you
(Department of Pathology1,Department of General Surgery2,People’s Hospital of Jizhou District,Tianjin 301900,China)
关键词:
NLRP3; 人乳头瘤病毒; 宫颈病变
Keywords:
NLRP3; Human papillomavirus; Cervical lesions
分类号:
R737.33
DOI:
10.3969/j.issn.1006-1959.2023.06.025
文献标志码:
A
摘要:
目的 探讨NLRP3炎症小体相关基因在HPV感染子宫颈细胞中的差异表达及与疾病发生发展的相关性。方法 收集2019年1月-2020年1月在我院进行常规HPV检测者2983例，根据检测结果分为正常组（1222例，常规HPV检测阴性）、低危HPV组（1023例）、高危HPV组（738例），比较各组一般临床资料，对低危HPV组和高危HPV组患者进行阴道镜检查并进行阴道镜下子宫颈组织活检；随访2年后对低危HPV组和高危HPV组再次进行检查，每组根据有无出现子宫颈上皮内瘤变（CIN）分为CIN亚组和non-CIN亚组。利用反转录-聚合酶链反应（RT-PCR）技术检测NLRP3炎症小体相关基因NLRP3、Caspase-1、IL-18、IL-1β、NF-kB和ASC的mRNA表达，蛋白质免疫印迹法（Western blot）检测其蛋白表达。结果 与正常组比较，低危HPV组和高危HPV组NLRP3、Caspase-1、IL-18、IL-1β、NF-kB的mRNA和蛋白表达水平均升高，差异有统计学意义（P＜0.05），但3组ASC的mRNA表达比较，差异有统计学意义（P＜0.05），而蛋白表达水平比较，差异无统计学意义（P＞0.05）；随访2年后，低危HPV组有409例发生CIN，高危HPV组有421例发生CIN，各组CIN组的NLRP3、Caspase-1、IL-18、IL-1β、NF-kB和ASC的mRNA和蛋白表达水平均高于non-CIN组，差异有统计学意义（P＜0.05）。结论 NLRP3炎症小体可能是HPV感染宫颈病变过程中重要的分子事件，NLRP3炎症小体有可能作为HPV感染宫颈病变的预测标志物。
Abstract:
Objective To investigate the differential expression of NLRP3 inflammasome-related genes in HPV-infected cervical cells and its correlation with the occurrence and development of the disease.Methods A total of 2983 patients who underwent routine HPV test in our hospital from January 2019 to January 2020 were collected. According to the test results, they were divided into normal group (1222 cases, negative for routine HPV test), low-risk HPV group (1023 cases) and high-risk HPV group (738 cases). The general clinical data of each group were compared. The patients in the low-risk HPV group and the high-risk HPV group were examined by colposcopy and cervical biopsy under colposcopy. After 2 years of follow-up, the low-risk HPV group and the high-risk HPV group were examined again. Each group was divided into CIN subgroup and non-CIN subgroup according to the presence or absence of cervical intraepithelial neoplasia (CIN). The mRNA expression of NLRP3 inflammasome-related genes NLRP3, caspase-1, IL-18, IL-1β, NF-kB and ASC was detected by reverse transcription-polymerase chain reaction (RT-PCR), and the protein expression was detected by Western blot.Results Compared with the normal group, the mRNA and protein expression levels of NLRP3, caspase-1, IL-18, IL-1β and NF-kB in the low-risk HPV group and the high-risk HPV group were increased, and the difference was statistically significant (P<0.05). However, there was a statistically significant difference in the mRNA expression of ASC among the three groups (P<0.05), but there was no significant difference in the protein expression level (P>0.05). After 2 years of follow-up, there were 409 cases of CIN in the low-risk HPV group and 421 cases of CIN in the high-risk HPV group. The mRNA and protein expression levels of NLRP3, caspase-1, IL-18, IL-1β, NF-kB and ASC in CIN subgroups were higher than those in non-CIN subgroups, and the differences were statistically significant (P<0.05).Conclusion NLRP3 inflammasome may be an important molecular event in the process of HPV infected cervical lesions, and NLRP3 inflammasome may be used as a predictive marker for HPV infected cervical lesions.

参考文献/References:

[1]张秀艳,纪利娜,梁紫影,等.Vδ1T细胞和TINs细胞表达情况与宫颈癌患者临床分期及预后的关系[J].免疫学杂志,2021,37(1):67-72.[2]Huang Y,Xu W,Zhou R.NLRP3 inflammasome activation and cell death[J].Cell Mol Immunol,2021,18(9):2114-2127.[3]Takano K,Kondo A,Kurose M,et al.Expression of Inflammasome-Associated Proteins in Human Oropharyngeal Squamous Cell Carcinoma[J].Otorhinolaryngol,2016,77:98-104.[4]Pontillo A,Bricher P,Leal VNC,et al.Role of inflammasome genetics in susceptibility to HPV infection and cervical cancer development[J].J Med Virol,2016,88(9):1646-1651. [5]Wu XX,Zhang HY,Qi W,et al.Nicotine promotes atherosclerosis via ROS-NLRP3 mediated endothlial cell pyroptosis[J].Cell Death Dis,2018,9(2):171.[6]杨小飞,谢宁娜,宋淑芳.内蒙中部地区妇科门诊就诊患者宫颈HPV感染及与宫颈病变相关性的研究[J].现代妇产科进展,2018,27(6):446-451.[7]Jr WS,Bacon MA,Bajaj A,et al.Cervical cancer:A global health crisis[J].Cancer,2017,123(13):2404-2412.[8]Berman TA,Schiller JT.Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases[J].Cancer,2017,123(12):2219-2229.[9]Nahand JS,Moghoofei M,Salmaninejad A,et al.Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: A review[J].Int J Cancer,2020,146(2):305-320.[10]Hoseini Z,Sepahvand F,Rashidi B,et al.NLRP3 inflammasome:Its regulation and involvement in atherosclerosis[J].J Cell Physiol,2018,233(3):2116-2132.[11]赵子龙,周国江,任玉峰,等.IL-1β、IL-6、IL-17的表达和HPV感染与宫颈癌的相关性研究[J].实用癌症杂志,2017,32(3):358-360.[12]张庆云,王莹,陈小江.宫颈癌术后感染状况及其与Caspase-1、IL-1β表达情况的相关性[J].实用癌症杂志,2021,36(3):423-425.[13]蒋维,徐建青,周芮.宫颈癌患者高危型HPV感染状况及与Caspase-1和IL-1β表达的相关性[J].中国妇幼保健,2021,36(10):2363-2366. [14]Bruno MT,Cassaro N,Garofalo S,et al.HPV16 persistent infection and recurrent disease after LEEP[J].Virol J,2019,16(1):148. [15]陈晴,杜辉,王纯,等.阴道镜下隐匿子宫颈上皮内瘤变Ⅲ级病变的HPV亚型感染特征及鳞状上皮厚度分析[J].中华妇产科杂志,2018,53(3):172-177.[16]张磊,毕庆庆,陈文,等.宫颈上皮内瘤变和宫颈癌患者人乳头瘤病毒基因型流行率和归因分析[J].中国全科医学,2019,22(17):2042-2046.[17]周方芳,桂涛,黄美华,等.宫颈高危型人乳头状瘤病毒感染中医证型、体质分布及相关危险因素的研究[J].实用医学杂志,2022,38(2):234-238.[18]Torres-Poveda K,Ruiz-Fraga I,Madrid-Marina V,et al.High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program[J].BMC Cancer,2019,19(1):1205.[19]岳帆,侯向萍,咸敏,等.6620例已婚妇女HPV感染现状及影响因素分析[J].分子诊断与治疗杂志,2022,14(3):512-515,520.[20]Kero K, Rautava J.HPV Infections in Heterosexual Couples: Mechanisms and Covariates of Virus Transmission[J].Acta Cytol,2019,63(2):143-147.

相似文献/References:

[1]莫宗平,刘 巧,蒋佳利.安岳地区女性高危型HPV基因分型结果分析[J].医学信息,2018,31(18):101.[doi:10.3969/j.issn.1006-1959.2018.18.031]
　MO Zong-ping,LIU Qiao,JIANG Jia-li.Analysis of the Results of High-risk HPV Genotyping in Women in Anyue Area[J].Journal of Medical Information,2018,31(06):101.[doi:10.3969/j.issn.1006-1959.2018.18.031]
[2]邬素珍,许焕英.宫颈人乳头瘤病毒感染的免疫研究进展[J].医学信息,2018,31(19):33.[doi:10.3969/j.issn.1006-1959.2018.19.012]
　WU Su-zhen,XU Huan-ying.Progress in Immunization of Cervical Human Papillomavirus Infection[J].Journal of Medical Information,2018,31(06):33.[doi:10.3969/j.issn.1006-1959.2018.19.012]
[3]李慧丹,赵文鸽,王学惠.Nox4在同型半胱氨酸介导的动脉粥样硬化中作用的研究[J].医学信息,2019,32(15):45.[doi:10.3969/j.issn.1006-1959.2019.15.015]
　LI Hui-dan,ZHAO Wen-ge,WANG Xue-hui.Research on the Role of Nox4 in Homocysteine-mediated Atherosclerosis[J].Journal of Medical Information,2019,32(06):45.[doi:10.3969/j.issn.1006-1959.2019.15.015]
[4]许生样.杭州地区男性人乳头瘤病毒感染特征分析[J].医学信息,2020,33(05):137.[doi:10.3969/j.issn.1006-1959.2020.05.043]
　XU Sheng-yang.Characteristics of Human Papillomavirus Infection in Male in Hangzhou[J].Journal of Medical Information,2020,33(06):137.[doi:10.3969/j.issn.1006-1959.2020.05.043]
[5]秦燕,王杏茶,方淑琴,等.承德市女性人乳头瘤病毒感染基因分型的临床分析[J].医学信息,2020,33(08):144.[doi:10.3969/j.issn.1006-1959.2020.08.047]
　QIN Yan,WANG Xing-cha,FANG Shu-qin,et al.Infection Status and Distribution Characteristics of Female HPV Subtypes in Chengde City from 2014 to 2017[J].Journal of Medical Information,2020,33(06):144.[doi:10.3969/j.issn.1006-1959.2020.08.047]
[6]代艳文,吴大富.宜昌地区妇女人乳头瘤病毒感染状况分析[J].医学信息,2020,33(16):143.[doi:10.3969/j.issn.1006-1959.2020.16.045]
　DAI Yan-wen,WU Da-fu.Analysis of Women’s Human Papillomavirus Infection in Yichang Area[J].Journal of Medical Information,2020,33(06):143.[doi:10.3969/j.issn.1006-1959.2020.16.045]
[7]张 晴,杨勇莉.p16在宫颈癌发生发展中的作用[J].医学信息,2022,35(01):59.[doi:10.3969/j.issn.1006-1959.2022.01.014]
　ZHANG Qing,YANG Yong-li.Role of p16 in the Development of Cervical Cancer[J].Journal of Medical Information,2022,35(06):59.[doi:10.3969/j.issn.1006-1959.2022.01.014]
[8]周爱萍.重组人干扰素α-2b注射液联合凝胶对宫颈HPV感染患者炎性因子水平的影响[J].医学信息,2022,35(06):162.[doi:10.3969/j.issn.1006-1959.2022.06.042]
　ZHOU Ai-ping.Effect of Recombinant Human Interferon α-2b Injection Combined with Gel on Inflammatory Factor Levels in Patients with Cervical HPV Infection[J].Journal of Medical Information,2022,35(06):162.[doi:10.3969/j.issn.1006-1959.2022.06.042]
[9]穆红茹.中晚期宫颈癌的非手术治疗进展[J].医学信息,2022,35(15):167.[doi:10.3969/j.issn.1006-1959.2022.15.040]
　MU Hong-ru.Advances in Nonsurgical Treatment of Cervical Cancer in the Middle and Late Stage[J].Journal of Medical Information,2022,35(06):167.[doi:10.3969/j.issn.1006-1959.2022.15.040]
[10]翁梦晴,韦彩萍,任文宁,等.基于CiteSpace的人乳头瘤病毒疫苗可视化分析[J].医学信息,2023,36(03):39.[doi:10.3969/j.issn.1006-1959.2023.03.009]
　WENG Meng-qing,WEI Cai-ping,REN Wen-ning,et al.Visual Analysis of Human Papillomavirus Vaccine Based on CiteSpace[J].Journal of Medical Information,2023,36(06):39.[doi:10.3969/j.issn.1006-1959.2023.03.009]

更新日期/Last Update: 1900-01-01